Silver sulfadiazine is a topical antimicrobial used in selected burns, contaminated wounds and localized skin infections. Its spectrum includes susceptible gram-positive and gram-negative bacteria and some yeasts or fungi. Specialist ophthalmic preparations have also been used in selected keratitis cases. Its role is local microbial control within a broader tissue-healing plan.
Group
Topical antimicrobial
Mechanism of Action
The silver-containing complex releases antimicrobial silver species that interact with microbial membranes, proteins and nucleic acids. Disruption of membrane integrity and essential enzyme systems impairs cellular function and survival. Sulfadiazine may contribute additional antimicrobial effects, but the activity of silver sulfadiazine differs from that of systemic sulfonamide treatment alone. Local availability governs exposure at the treated surface.
Dose Rates
Dogs
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Burn or wound antimicrobial care | Reference only | TOPICAL | Use a thin covering of an appropriate 1% preparation after wound assessment and cleaning. No verified universal application amount or treatment frequency is encoded. | |
| Burn antimicrobial care | Reference only | TOPICAL | Every 12–24 h | Apply an appropriate 1% cream about 1–2 mm thick once or twice daily; a suitable dressing may be used. Reassess tissue granulation and systemic absorption risk. |
| Localized bacterial skin infection | Reference only | TOPICAL | Every 12–24 h | Rub an appropriate thin amount into the affected area once or twice daily; may be useful for selected Pseudomonas lesions after diagnosis. |
Cats
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Burn or wound antimicrobial care | Reference only | TOPICAL | Use a thin covering of an appropriate 1% preparation after wound assessment and cleaning. No verified universal application amount or treatment frequency is encoded. | |
| Burn antimicrobial care | Reference only | TOPICAL | Every 12–24 h | Apply an appropriate 1% cream about 1–2 mm thick once or twice daily; a suitable dressing may be used. Reassess tissue granulation and systemic absorption risk. |
| Localized bacterial skin infection | Reference only | TOPICAL | Every 12–24 h | Rub an appropriate thin amount into the affected area once or twice daily; may be useful for selected Pseudomonas lesions after diagnosis. |
Horses
| Use / stage | Dose | Route | Schedule | Instructions |
|---|---|---|---|---|
| Burn or wound antimicrobial care | Reference only | TOPICAL | Use a thin covering of an appropriate 1% preparation after wound assessment and cleaning. No verified universal application amount or treatment frequency is encoded. | |
| Fungal keratitis | Reference only | TOPICAL | Every 6–24 h | Specialist table describes 1% silver sulfadiazine formulation every 6–24 hours. Use an ocular-suitable preparation selected for the lesion. |
| Burn antimicrobial care | Reference only | TOPICAL | Every 12–24 h | Apply an appropriate 1% cream about 1–2 mm thick once or twice daily; a suitable dressing may be used. Reassess tissue granulation and systemic absorption risk. |
| Localized bacterial skin infection | Reference only | TOPICAL | Every 12–24 h | Rub an appropriate thin amount into the affected area once or twice daily; may be useful for selected Pseudomonas lesions after diagnosis. |
| Specialist fungal keratitis cream technique | Reference only | TOPICAL | A reported local amount is 0.2 mL of 1% cream into the conjunctival sac, aseptically dispensed into a needle-free syringe. Frequent early treatment is reduced by response. Cream does not reliably pass through standard subpalpebral catheters; ophthalmic suitability must be explicitly assessed. |
Indications
- Prevention or treatment of selected bacterial contamination or infection in burns and open wounds.
- Local treatment of selected susceptible skin infections, including some Pseudomonas-associated lesions.
- Specialist adjunctive treatment of selected fungal keratitis using an ophthalmically suitable preparation, with organism-specific support.
Contraindications
- Hypersensitivity to the formulation
Interactions
- Do not combine topical wound products without an explicit compatibility plan.
Adverse effects
- Local irritation
- Potential systemic sulfonamide effects after extensive absorption
Toxicity
Extensive application may increase systemic exposure; assess renal and hematologic effects if treatment area is large or prolonged.
Preparations
| Preparation | Form | Strength | Route |
|---|---|---|---|
| Silver sulfadiazine cream 1% Dermatologic cream: 10 mg silver sulfadiazine per gram. Not automatically an ophthalmic preparation. | Other | 10 mg / g | TOPICAL |
| Silvadene cream 1% (10 mg/g) Water-miscible dermatologic cream. An ophthalmic plan requires separate formulation and aseptic-handling assessment. | Other | 10 mg / g | TOPICAL |
Monitoring and Administration
Remove devitalized tissue and clean the wound as indicated; a topical antimicrobial does not replace debridement or systemic treatment when required.
Avoid wound licking. Standard dermatologic cream is not automatically suitable for the eye; ophthalmic use requires specialist formulation selection.
Dermatologic cream is not labeled as an ophthalmic preparation. Specialist corneal use described in veterinary literature does not make every skin product suitable for the eye; use sterile handling and an explicit ophthalmic plan.
Silver sulfadiazine can retard granulation; avoid routine application to non-granulated wounds. Sulfonamide-sensitive patients may react, and extensive/prolonged use may produce systemic sulfonamide effects including hematologic changes or dry eye.
Prolonged corneal exposure has been associated with argyrism. Select treatment and debridement from the lesion rather than automatically extending frequent applications.